Evidence explainerMen's Hormones & TRT
Clomiphene for Men: How It Raises Testosterone, What Studies Show, and the Off-Label Caveats
Clomiphene citrate is FDA-approved only for ovulation problems in women, yet clinicians prescribe it off-label to men with low testosterone who want to keep their fertility. The studies are mostly observational, and estradiol and vision changes need watching.
Key takeaways
- Clomiphene's FDA label covers ovulatory dysfunction in women only and says there are no adequate, well-controlled studies showing it works for male infertility [1].
- The Endocrine Society notes it has been used empirically in men with low pituitary signals but that neither its efficacy nor safety has been shown in randomized trials [2].
- In 400 men treated for low testosterone, 88% of those on clomiphene for more than 3 years reached normal levels and 77% reported better symptoms; estradiol rose [3].
- Polycythemia was far less common on clomiphene than on TRT in a multi-center comparison: 1.7% vs 11.2% [4].
- The label warns of blurred vision, spots or flashes that rise with dose and duration and may rarely be irreversible [1].
How it works, and who it can work for
Clomiphene is a selective estrogen receptor modulator (SERM). It blocks estradiol's feedback on the hypothalamus and pituitary, which raises LH and FSH so the testes make more of their own testosterone and keep making sperm [5].
Because it works through the testes, it needs testes that can respond. The AUA notes that if testosterone stays low while LH is high on a SERM, the man likely has testicular dysfunction and a higher dose is unlikely to help [5].
Off-label status
Clomiphene is indicated for ovulatory dysfunction in women who want to become pregnant [1]. The label adds that testicular tumors and gynecomastia have been reported in men using it, with the cause-and-effect relationship unknown [1].
Among the alternatives to testosterone (SERMs, aromatase inhibitors and hCG), the AUA notes that only hCG is FDA-approved for use in men, and cautions that the benefits shown for testosterone therapy cannot be assumed for these alternatives [5].
What the studies show
Most of the evidence comes from single centers, looks back at records, or lacks a placebo group, which is why the Endocrine Society says clomiphene's efficacy and safety have not been demonstrated in randomized trials [2]. The main studies:
- 86 young men (mean age 29) with two morning testosterone levels below 300 ng/dL, treated a mean 19 months: testosterone, LH and FSH all rose, symptom scores improved, and no major side effects were recorded [6].
- 400 men treated a mean 25.5 months at two institutions: among the 120 treated for more than 3 years, 88% reached normal testosterone, 77% reported symptom improvement and 8% reported side effects [3].
- 188 men on clomiphene vs 175 on TRT: testosterone rose by a similar amount (367.6 vs 333.1 ng/dL), but hematocrit rose 0.6 vs 3.0 points and polycythemia occurred in 1.7% vs 11.2% [4]. The TRT group was older and treated longer; the difference held after adjusting for age, site, smoking and starting hematocrit [4].
- Randomized trials of SERMs vs testosterone vs placebo, cited by the AUA, found sperm concentration maintained on a SERM but significantly reduced on testosterone [5].
Side effects to know
The label and the studies above report these effects.
- Vision: blurring, spots or flashes can occur, become more common with higher total dose or longer use, are usually reversible, but prolonged and possibly irreversible cases have been reported; the label warns these can make driving more hazardous [1].
- Estradiol: levels rose significantly in the 400-man study [3].
- Reported in men on clomiphene for more than 3 years: mood changes (5 men), blurred vision (3) and breast tenderness (2) [3].
- Other effects listed by the AUA for clomiphene: flushing, headache and abdominal discomfort [5].
Monitoring on clomiphene
The AUA's follow-up points for men on a SERM are below; our TRT blood tests guide has the full schedule.
Clomiphene vs enclomiphene
Clomiphene is a mixture of two isomers, zuclomiphene and enclomiphene [7]. Enclomiphene is sold separately by some online clinics; prices and access are in enclomiphene online, and its trials are compared with TRT in the related reading below.
For fertility-sparing options more broadly, including hCG, see TRT and fertility.
This guide explains what guidelines and studies say. It is not medical advice: a licensed clinician decides whether testosterone or any alternative is right for you, and at what dose.
Quick answers
Is clomiphene FDA-approved for men?
No. It is approved for ovulatory dysfunction in women, and its label says adequate studies have not shown it works for male infertility [1]. Use in men is off-label.
Does clomiphene raise testosterone as much as TRT?
In one comparison the average rise was similar (367.6 ng/dL on clomiphene vs 333.1 on TRT), with much less polycythemia [4]. It only works if the testes can respond [5].
Does clomiphene preserve fertility?
It keeps the brain's signals to the testes running, and randomized trials cited by the AUA found sperm concentration maintained on SERMs but reduced on testosterone [5]. Its label notes no adequate studies of male infertility [1].
What are the side effects of clomiphene in men?
Vision changes that can rarely be prolonged [1], higher estradiol [3], and less often mood changes or breast tenderness [3]. The AUA also lists flushing, headache and abdominal discomfort [5].
What is the difference between clomiphene and enclomiphene?
Clomiphene is a mixture of two isomers, zuclomiphene and enclomiphene [7]; enclomiphene is one of them.
More in Men's Hormones & TRT
- Men's Hormones & TRT hub
- TRT Side Effects: Hematocrit, Acne, Sleep Apnea, Fertility and What Guidelines Do About Each
- TRT and Fertility: hCG, Clomiphene, Enclomiphene and What the AUA Guidelines Allow
- Testosterone and Heart Risk: What the TRAVERSE Trial Found and What the FDA Changed
- TRT Blood Tests: What Gets Checked Before and During Testosterone Therapy, and When
- TRT vs Natural Testosterone Boosters: Which Supplements Have Trials, and How Big the Effects Are
References
- [1]Clomid (clomiphene citrate) tablets prescribing information. DailyMed, U.S. National Library of Medicine, 2025.
- [2]Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2018.
- [3]Long-Term Safety and Efficacy of Clomiphene Citrate for the Treatment of Hypogonadism. J Urol, 2019.
- [4]A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study. J Urol, 2017.
- [5]Evaluation and Management of Testosterone Deficiency (2024). American Urological Association, 2024.
- [6]Outcomes of clomiphene citrate treatment in young hypogonadal men. BJU Int, 2012.
- [7]Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. J Sex Med, 2013.
